These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9411349)

  • 1. [Experience with ipriflavone therapy in postmenopausal osteoporosis].
    Szántó F
    Orv Hetil; 1997 Nov; 138(44):2801-3. PubMed ID: 9411349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ipriflavone].
    Kitatani K; Morii H
    Nihon Rinsho; 1998 Jun; 56(6):1537-43. PubMed ID: 9648478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone.
    Moscarini M; Patacchiola F; Spacca G; Palermo P; Caserta D; Valenti M
    Gynecol Endocrinol; 1994 Sep; 8(3):203-7. PubMed ID: 7847106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized comparative study using carbocalcitonin i.m. vs carbocalcitonin nasal spray vs ipriflavone x os in the treatment of post-menopausal osteoporosis].
    Lobianco R; Merola B; Lupoli G; Cocca A; Guarino M; Pia M; Guerriero S; Lombardi G
    Minerva Endocrinol; 1992; 17(2):79-84. PubMed ID: 1296148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipriflavone not effective for osteoporosis.
    Harv Womens Health Watch; 2001 Jun; 8(10):5. PubMed ID: 11439282
    [No Abstract]   [Full Text] [Related]  

  • 6. Ipriflavone: background.
    Gennari C
    Calcif Tissue Int; 1997; 61 Suppl 1():S3-4. PubMed ID: 9263607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Place of ipriflavone in the therapy of osteoporosis].
    Zsuzsanna B
    Acta Pharm Hung; 1995 Nov; 65(6):229-32. PubMed ID: 8742631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipriflavone: an important bone-building isoflavone.
    Head KA
    Altern Med Rev; 1999 Feb; 4(1):10-22. PubMed ID: 9988779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal pain in postmenopausal women with osteoporosis: prevalence and course during raloxifene treatment in a prospective observational study of 6 months duration.
    Scharla S; Oertel H; Helsberg K; Kessler F; Langer F; Nickelsen T
    Curr Med Res Opin; 2006 Dec; 22(12):2393-402. PubMed ID: 17257453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.
    Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG
    Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis.
    Kovács AB
    Agents Actions; 1994 Mar; 41(1-2):86-7. PubMed ID: 8079827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
    Gennari C; Agnusdei D; Crepaldi G; Isaia G; Mazzuoli G; Ortolani S; Bufalino L; Passeri M
    Menopause; 1998; 5(1):9-15. PubMed ID: 9689189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new treatment possibility for osteoporosis with osteochin (ipriflavone) tablets].
    Bossányi A; Bucsi L
    Magy Traumatol Orthop Helyreallito Seb; 1989; 32(2):109-15. PubMed ID: 2570885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of soybean isoflavones on relieving menopausal syndrome and osteoporosis].
    Liu Z; Wang Y
    Wei Sheng Yan Jiu; 2007 Sep; 36(5):643-5. PubMed ID: 18095582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of osteoquin in treating the postmenopausal and senile forms of osteoporosis].
    Rodionova SS
    Ter Arkh; 1995; 67(10):43-5. PubMed ID: 8779104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the OSTA index for discriminating between high and low probability of femoral neck and lumbar spine osteoporosis among Thai postmenopausal women.
    Geater S; Leelawattana R; Geater A
    J Med Assoc Thai; 2004 Nov; 87(11):1286-92. PubMed ID: 15825701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy and its isoflavones: a review of their effects on bone density.
    Brynin R
    Altern Med Rev; 2002 Aug; 7(4):317-27. PubMed ID: 12197783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intramuscular clodronate on bone mass and metabolism in osteoporotic women.
    Gnudi S; Lisi L; Fini M; Malavolta N
    Int J Tissue React; 2001; 23(1):33-7. PubMed ID: 11392061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.